NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in securities of Spectrum
CEDARHURST, NY, Nov. 09, 2022 (GLOBE NEWSWIRE) — The securities litigation practice of Kuznicki Law PLLC is issuing this warning to shareholders of Centessa Pharmaceuticals
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) Lifshitz Law PLLC announces an investigation into a possible breach of
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announce that it has filed a securities class action in the United States
DelveInsights, “Insight into the major depressive disorder pipeline2022″, The report provides comprehensive insights into Over 75 companies and over 75 drugs in the pipeline in
DelveInsights, “Insight into the ulcerative colitis pipeline, 2022,” the report provides in-depth insights into 110+ companies and 110+ pipeline drugs in the Ulcerative Colitis (UC)
DelveInsights, “Insight into the obesity pipeline, 2022,” the report provides deep insights into over 120 companies and over 120 pipeline drugs in the obesity pipeline
DelveInsights, “Insight into the Rheumatoid Arthritis pipeline, 2022,” the report provides in-depth insights into 120+ companies and 120+ pipeline drugs in the Rheumatoid Arthritis (RA)
NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR)
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of TFF Pharmaceuticals, Inc. (“TFF” or the “Company”)
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in securities of Spectrum
CEDARHURST, NY, Nov. 09, 2022 (GLOBE NEWSWIRE) — The securities litigation practice of Kuznicki Law PLLC is issuing this warning to shareholders of Centessa Pharmaceuticals
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) Lifshitz Law PLLC announces an investigation into a possible breach of
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announce that it has filed a securities class action in the United States
DelveInsights, “Insight into the major depressive disorder pipeline2022″, The report provides comprehensive insights into Over 75 companies and over 75 drugs in the pipeline in
DelveInsights, “Insight into the ulcerative colitis pipeline, 2022,” the report provides in-depth insights into 110+ companies and 110+ pipeline drugs in the Ulcerative Colitis (UC)
DelveInsights, “Insight into the obesity pipeline, 2022,” the report provides deep insights into over 120 companies and over 120 pipeline drugs in the obesity pipeline
DelveInsights, “Insight into the Rheumatoid Arthritis pipeline, 2022,” the report provides in-depth insights into 120+ companies and 120+ pipeline drugs in the Rheumatoid Arthritis (RA)
NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR)
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of TFF Pharmaceuticals, Inc. (“TFF” or the “Company”)
